According to this latest study, the 2021 growth of Biosimilars of Rituximab will have significant change from previous year. By the most conservative estimates of global Biosimilars of Rituximab market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Biosimilars of Rituximab market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilars of Rituximab market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

500mg

100mg

Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Hospital Pharmacy

Retail Pharmacy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Amgen

AryoGen Pharmed

Biocad

Cadila Pharmaceuticals

Celltrion

Dr Reddy’s Laboratories

Teva

Hetero Group

Innovent Biologics

Intas Biopharmaceuticals

Mylan

Probiomed

TRPharma

Zenotech Laboratories

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Biosimilars of Rituximab Consumption 2016-2026

2.1.2 Biosimilars of Rituximab Consumption CAGR by Region

2.2 Biosimilars of Rituximab Segment by Type

2.2.1 500mg

2.2.2 100mg

2.2.3 Other

2.3 Biosimilars of Rituximab Sales by Type

2.3.1 Global Biosimilars of Rituximab Sales Market Share by Type (2016-2021)

2.3.2 Global Biosimilars of Rituximab Revenue and Market Share by Type (2016-2021)

2.3.3 Global Biosimilars of Rituximab Sale Price by Type (2016-2021)

2.4 Biosimilars of Rituximab Segment by Application

2.4.1 Hospital Pharmacy

2.4.2 Retail Pharmacy

2.5 Biosimilars of Rituximab Sales by Application

2.5.1 Global Biosimilars of Rituximab Sale Market Share by Application (2016-2021)

2.5.2 Global Biosimilars of Rituximab Revenue and Market Share by Application (2016-2021)

2.5.3 Global Biosimilars of Rituximab Sale Price by Application (2016-2021)

3 Global Biosimilars of Rituximab by Company

3.1 Global Biosimilars of Rituximab Sales Market Share by Company

3.1.1 Global Biosimilars of Rituximab Sales by Company (2019-2021)

3.1.2 Global Biosimilars of Rituximab Sales Market Share by Company (2019-2021)

3.2 Global Biosimilars of Rituximab Revenue Market Share by Company

3.2.1 Global Biosimilars of Rituximab Revenue by Company (2019-2021)

3.2.2 Global Biosimilars of Rituximab Revenue Market Share by Company (2019-2021)

3.3 Global Biosimilars of Rituximab Sale Price by Company

3.4 Global Manufacturers Biosimilars of Rituximab Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Biosimilars of Rituximab Product Location Distribution

3.4.2 Players Biosimilars of Rituximab Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Biosimilars of Rituximab by Region

4.1 Global Biosimilars of Rituximab by Region

4.1.1 Global Biosimilars of Rituximab Sales by Region

4.1.2 Global Biosimilars of Rituximab Revenue by Region

4.2 Americas Biosimilars of Rituximab Sales Growth

4.3 APAC Biosimilars of Rituximab Sales Growth

4.4 Europe Biosimilars of Rituximab Sales Growth

4.5 Middle East & Africa Biosimilars of Rituximab Sales Growth

5 Americas

5.1 Americas Biosimilars of Rituximab Sales by Country

5.1.1 Americas Biosimilars of Rituximab Sales by Country (2016-2021)

5.1.2 Americas Biosimilars of Rituximab Revenue by Country (2016-2021)

5.2 Americas Biosimilars of Rituximab Sales by Type

5.3 Americas Biosimilars of Rituximab Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Biosimilars of Rituximab Sales by Region

6.1.1 APAC Biosimilars of Rituximab Sales by Region (2016-2021)

6.1.2 APAC Biosimilars of Rituximab Revenue by Region (2016-2021)

6.2 APAC Biosimilars of Rituximab Sales by Type

6.3 APAC Biosimilars of Rituximab Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Biosimilars of Rituximab by Country

7.1.1 Europe Biosimilars of Rituximab Sales by Country (2016-2021)

7.1.2 Europe Biosimilars of Rituximab Revenue by Country (2016-2021)

7.2 Europe Biosimilars of Rituximab Sales by Type

7.3 Europe Biosimilars of Rituximab Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Biosimilars of Rituximab by Country

8.1.1 Middle East & Africa Biosimilars of Rituximab Sales by Country (2016-2021)

8.1.2 Middle East & Africa Biosimilars of Rituximab Revenue by Country (2016-2021)

8.2 Middle East & Africa Biosimilars of Rituximab Sales by Type

8.3 Middle East & Africa Biosimilars of Rituximab Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Biosimilars of Rituximab Distributors

10.3 Biosimilars of Rituximab Customer

11 Global Biosimilars of Rituximab Market Forecast

11.1 Global Biosimilars of Rituximab Forecast by Region

11.1.1 Global Biosimilars of Rituximab Forecast by Regions (2021-2026)

11.2.2 Global Biosimilars of Rituximab Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Biosimilars of Rituximab Forecast by Type

11.7 Global Biosimilars of Rituximab Forecast by Application

12 Key Players Analysis

12.1 Amgen

12.1.1 Amgen Company Information

12.1.2 Amgen Biosimilars of Rituximab Product Offered

12.1.3 Amgen Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Amgen Main Business Overview

12.1.5 Amgen Latest Developments

12.2 AryoGen Pharmed

12.2.1 AryoGen Pharmed Company Information

12.2.2 AryoGen Pharmed Biosimilars of Rituximab Product Offered

12.2.3 AryoGen Pharmed Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 AryoGen Pharmed Main Business Overview

12.2.5 AryoGen Pharmed Latest Developments

12.3 Biocad

12.3.1 Biocad Company Information

12.3.2 Biocad Biosimilars of Rituximab Product Offered

12.3.3 Biocad Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Biocad Main Business Overview

12.3.5 Biocad Latest Developments

12.4 Cadila Pharmaceuticals

12.4.1 Cadila Pharmaceuticals Company Information

12.4.2 Cadila Pharmaceuticals Biosimilars of Rituximab Product Offered

12.4.3 Cadila Pharmaceuticals Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Cadila Pharmaceuticals Main Business Overview

12.4.5 Cadila Pharmaceuticals Latest Developments

12.5 Celltrion

12.5.1 Celltrion Company Information

12.5.2 Celltrion Biosimilars of Rituximab Product Offered

12.5.3 Celltrion Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Celltrion Main Business Overview

12.5.5 Celltrion Latest Developments

12.6 Dr Reddy’s Laboratories

12.6.1 Dr Reddy’s Laboratories Company Information

12.6.2 Dr Reddy’s Laboratories Biosimilars of Rituximab Product Offered

12.6.3 Dr Reddy’s Laboratories Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Dr Reddy’s Laboratories Main Business Overview

12.6.5 Dr Reddy’s Laboratories Latest Developments

12.7 Teva

12.7.1 Teva Company Information

12.7.2 Teva Biosimilars of Rituximab Product Offered

12.7.3 Teva Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Teva Main Business Overview

12.7.5 Teva Latest Developments

12.8 Hetero Group

12.8.1 Hetero Group Company Information

12.8.2 Hetero Group Biosimilars of Rituximab Product Offered

12.8.3 Hetero Group Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Hetero Group Main Business Overview

12.8.5 Hetero Group Latest Developments

12.9 Innovent Biologics

12.9.1 Innovent Biologics Company Information

12.9.2 Innovent Biologics Biosimilars of Rituximab Product Offered

12.9.3 Innovent Biologics Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Innovent Biologics Main Business Overview

12.9.5 Innovent Biologics Latest Developments

12.10 Intas Biopharmaceuticals

12.10.1 Intas Biopharmaceuticals Company Information

12.10.2 Intas Biopharmaceuticals Biosimilars of Rituximab Product Offered

12.10.3 Intas Biopharmaceuticals Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Intas Biopharmaceuticals Main Business Overview

12.10.5 Intas Biopharmaceuticals Latest Developments

12.11 Mylan

12.11.1 Mylan Company Information

12.11.2 Mylan Biosimilars of Rituximab Product Offered

12.11.3 Mylan Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Mylan Main Business Overview

12.11.5 Mylan Latest Developments

12.12 Probiomed

12.12.1 Probiomed Company Information

12.12.2 Probiomed Biosimilars of Rituximab Product Offered

12.12.3 Probiomed Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Probiomed Main Business Overview

12.12.5 Probiomed Latest Developments

12.13 TRPharma

12.13.1 TRPharma Company Information

12.13.2 TRPharma Biosimilars of Rituximab Product Offered

12.13.3 TRPharma Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 TRPharma Main Business Overview

12.13.5 TRPharma Latest Developments

12.14 Zenotech Laboratories

12.14.1 Zenotech Laboratories Company Information

12.14.2 Zenotech Laboratories Biosimilars of Rituximab Product Offered

12.14.3 Zenotech Laboratories Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Zenotech Laboratories Main Business Overview

12.14.5 Zenotech Laboratories Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Biosimilars of Rituximab Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of 500mg

Table 3. Major Players of 100mg

Table 4. Major Players of Other

Table 5. Global Biosimilars of Rituximab Sales by Type (2016-2021) & (K Units)

Table 6. Global Biosimilars of Rituximab Sales Market Share by Type (2016-2021)

Table 7. Global Biosimilars of Rituximab Revenue by Type (2016-2021) & ($ million)

Table 8. Global Biosimilars of Rituximab Revenue Market Share by Type (2016-2021)

Table 9. Global Biosimilars of Rituximab Sale Price by Type (2016-2021)

Table 10. Global Biosimilars of Rituximab Sales by Application (2016-2021) & (K Units)

Table 11. Global Biosimilars of Rituximab Sales Market Share by Application (2016-2021)

Table 12. Global Biosimilars of Rituximab Value by Application (2016-2021)

Table 13. Global Biosimilars of Rituximab Revenue Market Share by Application (2016-2021)

Table 14. Global Biosimilars of Rituximab Sale Price by Application (2016-2021)

Table 15. Global Biosimilars of Rituximab Sales by Company (2019-2021) & (K Units)

Table 16. Global Biosimilars of Rituximab Sales Market Share by Company (2019-2021)

Table 17. Global Biosimilars of Rituximab Revenue by Company (2019-2021) ($ Millions)

Table 18. Global Biosimilars of Rituximab Revenue Market Share by Company (2019-2021)

Table 19. Global Biosimilars of Rituximab Sale Price by Company (2019-2021)

Table 20. Key Manufacturers Biosimilars of Rituximab Producing Area Distribution and Sales Area

Table 21. Players Biosimilars of Rituximab Products Offered

Table 22. Biosimilars of Rituximab Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Biosimilars of Rituximab Sales by Region (2016-2021) (K Units)

Table 26. Global Biosimilars of Rituximab Sales Market Share by Region (2016-2021)

Table 27. Global Biosimilars of Rituximab Revenue by Region (2016-2021) & ($ Millions)

Table 28. Global Biosimilars of Rituximab Revenue Market Share by Region (2016-2021)

Table 29. Americas Biosimilars of Rituximab Sales by Country (2016-2021) & (K Units)

Table 30. Americas Biosimilars of Rituximab Sales Market Share by Country (2016-2021)

Table 31. Americas Biosimilars of Rituximab Revenue by Country (2016-2021) & ($ Millions)

Table 32. Americas Biosimilars of Rituximab Revenue Market Share by Country (2016-2021)

Table 33. Americas Biosimilars of Rituximab Sales by Type (2016-2021) & (K Units)

Table 34. Americas Biosimilars of Rituximab Sales Market Share by Type (2016-2021)

Table 35. Americas Biosimilars of Rituximab Sales by Application (2016-2021) & (K Units)

Table 36. Americas Biosimilars of Rituximab Sales Market Share by Application (2016-2021)

Table 37. APAC Biosimilars of Rituximab Sales by Region (2016-2021) & (K Units)

Table 38. APAC Biosimilars of Rituximab Sales Market Share by Region (2016-2021)

Table 39. APAC Biosimilars of Rituximab Revenue by Region (2016-2021) & ($ Millions)

Table 40. APAC Biosimilars of Rituximab Revenue Market Share by Region (2016-2021)

Table 41. APAC Biosimilars of Rituximab Sales by Type (2016-2021) & (K Units)

Table 42. APAC Biosimilars of Rituximab Sales Market Share by Type (2016-2021)

Table 43. APAC Biosimilars of Rituximab Sales by Application (2016-2021) & (K Units)

Table 44. APAC Biosimilars of Rituximab Sales Market Share by Application (2016-2021)

Table 45. Europe Biosimilars of Rituximab Sales by Country (2016-2021) & (K Units)

Table 46. Europe Biosimilars of Rituximab Sales Market Share by Country (2016-2021)

Table 47. Europe Biosimilars of Rituximab Revenue by Country (2016-2021) & ($ Millions)

Table 48. Europe Biosimilars of Rituximab Revenue Market Share by Country (2016-2021)

Table 49. Europe Biosimilars of Rituximab Sales by Type (2016-2021) & (K Units)

Table 50. Europe Biosimilars of Rituximab Sales Market Share by Type (2016-2021)

Table 51. Europe Biosimilars of Rituximab Sales by Application (2016-2021) & (K Units)

Table 52. Europe Biosimilars of Rituximab Sales Market Share by Application (2016-2021)

Table 53. Middle East & Africa Biosimilars of Rituximab Sales by Country (2016-2021) & (K Units)

Table 54. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Country (2016-2021)

Table 55. Middle East & Africa Biosimilars of Rituximab Revenue by Country (2016-2021) & ($ Millions)

Table 56. Middle East & Africa Biosimilars of Rituximab Revenue Market Share by Country (2016-2021)

Table 57. Middle East & Africa Biosimilars of Rituximab Sales by Type (2016-2021) & (K Units)

Table 58. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Type (2016-2021)

Table 59. Middle East & Africa Biosimilars of Rituximab Sales by Application (2016-2021) & (K Units)

Table 60. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Application (2016-2021)

Table 61. Key and Potential Regions of Biosimilars of Rituximab

Table 62. Key Application and Potential Industries of Biosimilars of Rituximab

Table 63. Key Challenges of Biosimilars of Rituximab

Table 64. Key Trends of Biosimilars of Rituximab

Table 65. Biosimilars of Rituximab Distributors List

Table 66. Biosimilars of Rituximab Customer List

Table 67. Global Biosimilars of Rituximab Sales Forecast by Region (2021-2026) & (K Units)

Table 68. Global Biosimilars of Rituximab Consumption Market Forecast by Region

Table 69. Global Biosimilars of Rituximab Revenue Forecast by Region (2021-2026) & ($ millions)

Table 70. Global Biosimilars of Rituximab Revenue Market Share Forecast by Region (2021-2026)

Table 71. Americas Biosimilars of Rituximab Sales Forecast by Country (2021-2026) & (K Units)

Table 72. Americas Biosimilars of Rituximab Revenue Forecast by Country (2021-2026) & ($ millions)

Table 73. APAC Biosimilars of Rituximab Sales Forecast by Region (2021-2026) & (K Units)

Table 74. APAC Biosimilars of Rituximab Revenue Forecast by Region (2021-2026) & ($ millions)

Table 75. Europe Biosimilars of Rituximab Sales Forecast by Country (2021-2026) & (K Units)

Table 76. Europe Biosimilars of Rituximab Revenue Forecast by Country (2021-2026) & ($ millions)

Table 77. Middle East & Africa Biosimilars of Rituximab Sales Forecast by Country (2021-2026) & (K Units)

Table 78. Middle East & Africa Biosimilars of Rituximab Revenue Forecast by Country (2021-2026) & ($ millions)

Table 79. Global Biosimilars of Rituximab Sales Forecast by Type (2021-2026) & (K Units)

Table 80. Global Biosimilars of Rituximab Sales Market Share Forecast by Type (2021-2026)

Table 81. Global Biosimilars of Rituximab Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 82. Global Biosimilars of Rituximab Revenue Market Share Forecast by Type (2021-2026)

Table 83. Global Biosimilars of Rituximab Sales Forecast by Application (2021-2026) & (K Units)

Table 84. Global Biosimilars of Rituximab Sales Market Share Forecast by Application (2021-2026)

Table 85. Global Biosimilars of Rituximab Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 86. Global Biosimilars of Rituximab Revenue Market Share Forecast by Application (2021-2026)

Table 87. Amgen Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 88. Amgen Biosimilars of Rituximab Product Offered

Table 89. Amgen Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 90. Amgen Main Business

Table 91. Amgen Latest Developments

Table 92. AryoGen Pharmed Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 93. AryoGen Pharmed Biosimilars of Rituximab Product Offered

Table 94. AryoGen Pharmed Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 95. AryoGen Pharmed Main Business

Table 96. AryoGen Pharmed Latest Developments

Table 97. Biocad Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 98. Biocad Biosimilars of Rituximab Product Offered

Table 99. Biocad Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 100. Biocad Main Business

Table 101. Biocad Latest Developments

Table 102. Cadila Pharmaceuticals Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 103. Cadila Pharmaceuticals Biosimilars of Rituximab Product Offered

Table 104. Cadila Pharmaceuticals Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 105. Cadila Pharmaceuticals Main Business

Table 106. Cadila Pharmaceuticals Latest Developments

Table 107. Celltrion Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 108. Celltrion Biosimilars of Rituximab Product Offered

Table 109. Celltrion Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 110. Celltrion Main Business

Table 111. Celltrion Latest Developments

Table 112. Dr Reddy’s Laboratories Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 113. Dr Reddy’s Laboratories Biosimilars of Rituximab Product Offered

Table 114. Dr Reddy’s Laboratories Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 115. Dr Reddy’s Laboratories Main Business

Table 116. Dr Reddy’s Laboratories Latest Developments

Table 117. Teva Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 118. Teva Biosimilars of Rituximab Product Offered

Table 119. Teva Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 120. Teva Main Business

Table 121. Teva Latest Developments

Table 122. Hetero Group Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 123. Hetero Group Biosimilars of Rituximab Product Offered

Table 124. Hetero Group Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 125. Hetero Group Main Business

Table 126. Hetero Group Latest Developments

Table 127. Innovent Biologics Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 128. Innovent Biologics Biosimilars of Rituximab Product Offered

Table 129. Innovent Biologics Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 130. Innovent Biologics Main Business

Table 131. Innovent Biologics Latest Developments

Table 132. Intas Biopharmaceuticals Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 133. Intas Biopharmaceuticals Biosimilars of Rituximab Product Offered

Table 134. Intas Biopharmaceuticals Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 135. Intas Biopharmaceuticals Main Business

Table 136. Intas Biopharmaceuticals Latest Developments

Table 137. Mylan Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 138. Mylan Biosimilars of Rituximab Product Offered

Table 139. Mylan Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 140. Mylan Main Business

Table 141. Mylan Latest Developments

Table 142. Probiomed Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 143. Probiomed Biosimilars of Rituximab Product Offered

Table 144. Probiomed Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 145. Probiomed Main Business

Table 146. Probiomed Latest Developments

Table 147. TRPharma Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 148. TRPharma Biosimilars of Rituximab Product Offered

Table 149. TRPharma Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 150. TRPharma Main Business

Table 151. TRPharma Latest Developments

Table 152. Zenotech Laboratories Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors

Table 153. Zenotech Laboratories Biosimilars of Rituximab Product Offered

Table 154. Zenotech Laboratories Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 155. Zenotech Laboratories Main Business

Table 156. Zenotech Laboratories Latest Developments

List of Figures

Figure 1. Picture of Biosimilars of Rituximab

Figure 2. Biosimilars of Rituximab Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Biosimilars of Rituximab Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Biosimilars of Rituximab Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Biosimilars of Rituximab Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of 500mg

Figure 10. Product Picture of 100mg

Figure 11. Product Picture of Other

Figure 12. Global Biosimilars of Rituximab Sales Market Share by Type in 2020

Figure 13. Global Biosimilars of Rituximab Revenue Market Share by Type (2016-2021)

Figure 14. Biosimilars of Rituximab Consumed in Hospital Pharmacy

Figure 15. Global Biosimilars of Rituximab Market: Hospital Pharmacy (2016-2021) & (K Units)

Figure 16. Biosimilars of Rituximab Consumed in Retail Pharmacy

Figure 17. Global Biosimilars of Rituximab Market: Retail Pharmacy (2016-2021) & (K Units)

Figure 18. Global Biosimilars of Rituximab Sales Market Share by Application (2016-2021)

Figure 19. Global Biosimilars of Rituximab Revenue Market Share by Application in 2020

Figure 20. Biosimilars of Rituximab Revenue Market by Company in 2020 ($ Million)

Figure 21. Global Biosimilars of Rituximab Revenue Market Share by Company in 2020

Figure 22. Global Biosimilars of Rituximab Sales Market Share by Regions (2016-2021)

Figure 23. Global Biosimilars of Rituximab Revenue Market Share by Region in 2020

Figure 24. Americas Biosimilars of Rituximab Sales 2016-2021 (K Units)

Figure 25. Americas Biosimilars of Rituximab Revenue 2016-2021 ($ Millions)

Figure 26. APAC Biosimilars of Rituximab Sales 2016-2021 (K Units)

Figure 27. APAC Biosimilars of Rituximab Revenue 2016-2021 ($ Millions)

Figure 28. Europe Biosimilars of Rituximab Sales 2016-2021 (K Units)

Figure 29. Europe Biosimilars of Rituximab Revenue 2016-2021 ($ Millions)

Figure 30. Middle East & Africa Biosimilars of Rituximab Sales 2016-2021 (K Units)

Figure 31. Middle East & Africa Biosimilars of Rituximab Revenue 2016-2021 ($ Millions)

Figure 32. Americas Biosimilars of Rituximab Sales Market Share by Country in 2020

Figure 33. Americas Biosimilars of Rituximab Revenue Market Share by Country in 2020

Figure 34. Americas Biosimilars of Rituximab Sales Market Share by Type in 2020

Figure 35. Americas Biosimilars of Rituximab Sales Market Share by Application in 2020

Figure 36. United States Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 37. Canada Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 38. Mexico Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 39. Brazil Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 40. APAC Biosimilars of Rituximab Sales Market Share by Region in 2020

Figure 41. APAC Biosimilars of Rituximab Revenue Market Share by Regions in 2020

Figure 42. APAC Biosimilars of Rituximab Sales Market Share by Type in 2020

Figure 43. APAC Biosimilars of Rituximab Sales Market Share by Application in 2020

Figure 44. China Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 45. Japan Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 46. Korea Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 47. Southeast Asia Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 48. India Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 49. Australia Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 50. Europe Biosimilars of Rituximab Sales Market Share by Country in 2020

Figure 51. Europe Biosimilars of Rituximab Revenue Market Share by Country in 2020

Figure 52. Europe Biosimilars of Rituximab Sales Market Share by Type in 2020

Figure 53. Europe Biosimilars of Rituximab Sales Market Share by Application in 2020

Figure 54. Germany Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 55. France Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 56. UK Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 57. Italy Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 58. Russia Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 59. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Country in 2020

Figure 60. Middle East & Africa Biosimilars of Rituximab Revenue Market Share by Country in 2020

Figure 61. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Type in 2020

Figure 62. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Application in 2020

Figure 63. Egypt Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 64. South Africa Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 65. Israel Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 66. Turkey Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 67. GCC Country Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles